BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3308664)

  • 1. The association of hepatic glycogen depletion with hyperammonemia in cirrhosis.
    Kabadi UM
    Hepatology; 1987; 7(5):821-4. PubMed ID: 3308664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma ammonia level in hepatic cirrhosis: role of glucagon.
    Kabadi UM; Eisenstein AB; Konda J
    Gastroenterology; 1985 Mar; 88(3):750-6. PubMed ID: 3881308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is hepatic glycogen content a regulator of glucagon secretion?
    Kabadi UM
    Metabolism; 1992 Feb; 41(2):113-5. PubMed ID: 1736031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gluconeogenesis from amino acids in determining fasting and absorptive levels of plasma ammonia in cirrhosis.
    Trevisani F; Bernardi M; Grilli F; De Palma R; Piazzi S; Patrono D; Gasbarrini G
    Am J Gastroenterol; 1988 Jun; 83(6):646-51. PubMed ID: 2897785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglucagonemia in hepatic cirrhosis: its relation to hepatocellular dysfunction and normalization on recovery.
    Kabadi UM; Eisenstein AB; Tucci J; Pellicone J
    Am J Gastroenterol; 1984 Feb; 79(2):143-9. PubMed ID: 6364796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overnight glucose infusion suppresses renal ammoniagenesis and reduces hyperammonaemia induced by a simulated bleed in cirrhotic patients.
    Mpabanzi L; Deutz N; Hayes PC; Dejong CH; Olde Damink SW; Jalan R
    Aliment Pharmacol Ther; 2012 Apr; 35(8):921-8. PubMed ID: 22360430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
    Clore JN; Post EP; Bailey DJ; Nestler JE; Blackard WG
    J Clin Endocrinol Metab; 1992 Mar; 74(3):660-6. PubMed ID: 1740502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of glucagon to stimulate hepatic glycogenolysis in well-nourished patients with mild cirrhosis.
    Petrides AS; De Fronzo RA
    Metabolism; 1994 Jan; 43(1):85-9. PubMed ID: 8289679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperglucagonemia in Laennec's cirrhosis. The role of portal-systemic shunting.
    Sherwin R; Joshi P; Hendler R; Felig P; Conn HO
    N Engl J Med; 1974 Jan; 290(5):239-42. PubMed ID: 4808927
    [No Abstract]   [Full Text] [Related]  

  • 10. Low serum T3 and raised reverse T3 levels in hepatic cirrhosis: role of glucagon.
    Kabadi UM; Kabadi MU; Premachandra BN
    Am J Gastroenterol; 1991 Oct; 86(10):1504-7. PubMed ID: 1928046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.
    Marchesini G; Zoli M; Dondi C; Angiolini A; Melli A; Pisi E
    Dig Dis Sci; 1982 May; 27(5):406-12. PubMed ID: 7042253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyperglucagonemia on hepatic glycogenolysis and gluconeogenesis after a prolonged fast.
    Hendrick GK; Frizzell RT; Williams PE; Cherrington AD
    Am J Physiol; 1990 May; 258(5 Pt 1):E841-9. PubMed ID: 2185665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperglucagonemia in liver cirrhosis with portal-systemic venous anastomoses: responses of plasma glucagon and gastric inhibitory polypeptide to oral or intravenous glucose in cirrhotics with normal or elevated fasting plasma glucose levels.
    McDonald TJ; Dupre J; Caussignac Y; Radziuk J; Van Vliet S
    Metabolism; 1979 Apr; 28(4):300-7. PubMed ID: 449682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis.
    Petersen KF; Krssak M; Navarro V; Chandramouli V; Hundal R; Schumann WC; Landau BR; Shulman GI
    Am J Physiol; 1999 Mar; 276(3):E529-35. PubMed ID: 10070020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis.
    Trevisani F; Bernardi M; Arienti V; Scrivano P; Mazziotti A; Cavallari A; Patrono D; Piazzi S; Gozzetti G; Gasbarrini G
    Hepatology; 1994 Feb; 19(2):329-38. PubMed ID: 8294090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of gluconeogenesis after a 3-day fast does not deplete liver glycogen in patients with NIDDM.
    Clore JN; Blackard WG
    Diabetes; 1994 Feb; 43(2):256-62. PubMed ID: 8288050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of supranormal liver glycogen content on hyperglucagonemia-induced liver glycogen breakdown.
    BĂ©langer P; Couturier K; Latour MG; Lavoie JM
    Eur J Appl Physiol; 2000 Nov; 83(4 -5):328-35. PubMed ID: 11138571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of hepatic glycogen metabolism in the rhesus monkey: effect of glucose, insulin, and glucagon administration.
    Curnow RT; Rayfield EJ; George DT; Zenser TV; De Rubertis F
    Am J Physiol; 1975 Jan; 228(1):80-7. PubMed ID: 167592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagon and glucose tolerance in liver cirrhosis.
    Greco AV; Altomonte L; Ghirlanda G; D'Anna LM; Manna R; Caputo S; Uccioli L
    Acta Endocrinol (Copenh); 1988 Jul; 118(3):337-45. PubMed ID: 2899368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy expenditure and substrate metabolism after oral fructose in patients with cirrhosis.
    Kruszynska YT; Meyer-Alber A; Wollen N; McIntyre N
    J Hepatol; 1993 Sep; 19(2):241-51. PubMed ID: 8301057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.